FDA Clearance Tracker · K223154
Magstim Horizon 3.0 TMS Therapy System, Horizon 3.0 System, Horizon 3.0, H3.0, Horizon 3.0 with StimGuide+
Last checked: Nov 19, 2026Latest source record: Mar 16, 2023 (this decision)Source: openFDAMethods & limitations
Decided
Mar 16, 2023
Substantially Equivalent
Time to decision
161 days
Received Oct 6, 2022. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K223154
- Device name
- Magstim Horizon 3.0 TMS Therapy System, Horizon 3.0 System, Horizon 3.0, H3.0, Horizon 3.0 with StimGuide+
- Applicant
- Magstim Company, Ltd.
- Applicant location
- Whitland, GB
- Received
- Oct 6, 2022
- Decided
- Mar 16, 2023
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device type
- Transcranial Magnetic Stimulator (OBP)
- Device class
- Class II
- Regulation
- 21 CFR 882.5805
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code OBP. The earliest in FDA's data is DEN070003, decided Oct 7, 2008.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K223154
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Magstim Company, Ltd.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K232235 · Decided Oct 25, 2023 · 90 days after receipt
Device type: Transcranial Magnetic Stimulator (OBP) · Neurology & Neurosurgery
K222171 · Decided Jan 13, 2023 · 176 days after receipt
Device type: Transcranial Magnetic Stimulator (OBP) · Neurology & Neurosurgery
- Magstim Horizon 3.0 TMS Therapy System, Horizon 3.0 System, Horizon 3.0, Horizon 3.0 with Navigation510(k)
K211389 · Decided Sep 14, 2021 · 132 days after receipt
Device type: Transcranial Magnetic Stimulator (OBP) · Neurology & Neurosurgery
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.